Plan B Rulemaking Intended To Establish Enforcement Procedures – Crawford
This article was originally published in The Tan Sheet
Executive Summary
The question of how to enforce an age-limit for OTC availability of Barr Labs' Plan B - rather than whether dual status for the drug could exist at all - was the main driver behind FDA's initiation of a rulemaking on the Rx-to-OTC switch application for the emergency contraceptive, according to former FDA Commissioner Lester Crawford
You may also be interested in...
Plan B Ruling Sets A Precedent That Could Give FDA Pause
March 23 ruling ordered FDA to reconsider a citizen petition requesting Plan B access for women of all ages.
Plan B Ruling Sets A Precedent That Could Give FDA Pause
March 23 ruling ordered FDA to reconsider a citizen petition requesting Plan B access for women of all ages.
Plan B Ruling Sets A Precedent That Could Give FDA Pause
The court ruling overturning FDA's denial of a citizen petition concerning access to the emergency contraceptive Plan B puts the administration in a pickle: to appeal the decision, or comply and allow a precedent that could trouble all federal agencies